Month: May 2017

Home » Archives for May 2017

Genetic test for BRCA1/2

BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. Men with harmful BRCA1 or BRCA2 mutations have a higher risk of prostate cancer. A Toronto Women’s College Hospital research study, The Screen Project, provides Canadians access to affordable population-based genetic testing for the BRCA gene mutation. Watch the video here.

Genetic test for BRCA1/2 Read More »

15-year metastasis-free survival in men on active surveillance in The Netherlands

According to new data reported at the annual meeting of the European Association of Urology in London, active surveillance of men diagnosed with low-risk prostate cancer was not associated with an elevated risk for metastatic disease at 15 years of follow-up. Read the article here.

15-year metastasis-free survival in men on active surveillance in The Netherlands Read More »

Finding common ground on how “best” to treat localized prostate cancer, and what to tell patients

With the goals of working together more collaboratively and to provide higher quality information for patients at the time of decision-making, a prostate cancer community partnership consensus (PCPC) panel was formed among six partnering centers in the Greater Toronto Area. Read the article here.

Finding common ground on how “best” to treat localized prostate cancer, and what to tell patients Read More »

Evidence of Exercise and Nutrition Trial dietary and physical activity modifications

There is increasing evidence that low levels of physical activity and diets low in fruit and vegetables and high in meat and dairy products are risk factors for prostate cancer disease progression. The Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) aimed to assess a diet and physical activity intervention in men undergoing radical prostatectomy for localized prostate cancer. Read the article here.

Evidence of Exercise and Nutrition Trial dietary and physical activity modifications Read More »

Could antidepressants stop prostate cancer from spreading?

In almost all cases where prostate cancer spreads to other areas of the body, the disease spreads to the bone first. In a new study, researchers reveal the discovery of an enzyme that helps prostate cancer cells to invade bone. Furthermore, certain antidepressant medications may have the potential to block this enzyme. Read the article here.

Could antidepressants stop prostate cancer from spreading? Read More »

Scroll to Top